The severity of keratitis was evaluated at 1, 3, and 5 days p

The severity of keratitis was evaluated at 1, 3, and 5 days p.i. and human corneal epithelium. In vitro experiment showed that SREC- mRNA and protein levels were significantly increased after activation. SREC- small interfering RNA treatment inhibited the expressions of LOX-1, IL-1, and TNF- in HCECs. The expressions of CLCX1, LOX-1, IL-1, and TNF- were elevated in mice with keratitis, which could be decreased by SREC-Cneutralizing antibody treatment. Conclusions SREC- is usually a key mediator in inflammatory response induced by keratitis. SREC- blockade could be a potential therapeutic approach for FK. species caused keratitis is one of the most common FK. However, there have been no new treatments since natamycin was launched in 1960s.2 Research around the pathogenesis and immune mechanisms of FK has become a hot spot in recent years, aiming to provide new targets for FK treatment. The innate immune system provides the first line of defense to recognize and resist pathogens against fungal contamination, and the pattern recognition receptors play a vital role in innate immunity,4 including Toll-like receptors (TLRs), C-type lectin-like receptors, and the scavenger receptor family.5C8 Scavenger receptor expressed by endothelial cell- (SREC-) is a member of scavenger receptor family F, known as SCARF-.9 It is an 86-kDa protein with an extended extracellular domain and first cloned from human umbilical vein endothelial cells.10C11 SREC- is expressed by multiple types of cells, such as endothelial cells, epithelial cells, dendritic cells, and macrophages,12C14 but the expression in corneal cells is largely unknown. It is reported that SREC- could identify modified self-ligands such as acetylated low-density Rabbit polyclonal to Tumstatin lipoprotein, warmth shock proteins, and apoptotic body,15C18 as well as several PROTAC ERRα ligand 2 exogenous ligands from microbial pathogens like lipopolysaccharide and lipoteichoic acid to mediate endocytosis and phagocytosis,19C20 thus participating in the host’s innate immunity.21 Moreover, studies have shown that SREC- could recognize and bind to -glucans present around the cell surface of and keratitis have yet to be determined. Our study investigated the role of SREC- in PROTAC ERRα ligand 2 innate immunity to keratitis in vitro and in vivo. Results indicated that SREC- expressed in HCECs and human/mice corneal epithelial cells, and SREC- mRNA and protein levels were upregulated after activation. SREC- inhibition could decrease the expression of inflammatory factors, including IL-1, TNF-, and LOX-1, as well as the trending factor CXCL1 that is elevated in keratitis. Thus, our study suggested that SREC- works as an important member of innate immunity during keratitis, which could be a potential therapeutic or an additional target for FK. Methods Clinical Specimens Six patients (four females and two males, 40C50 years old) with FK underwent penetrating keratoplasty at the Department of Ophthalmology (The Affiliated Hospital of Qingdao University or college) were included. The patients enrolled in the research were diagnosed clinically by staining of corneal scrapings, fungal culture (verified growth), or confocal microscopy at 25 to 30 days before the keratoplasty. All the samples were extracted during the keratoplasty. In total, six healthy corneal tissue samples from the remaining peripheral tissues of donor corneas and six patients (six eyes) with contamination after corneal transplantation were utilized for immunofluorescence analysis. All patients gave their informed consent for inclusion before they participated in the study. Research adhered to the tenets of the Declaration of Helsinki. The agreement of PROTAC ERRα ligand 2 patients was obtained and the informed consents were signed for specimen management. The experiment experienced the approval of the hospital’s ethics committee.7 Culture standard strain 3.0772 (China General Microbiological Culture Collection Center, Beijing, China) was cultured in Sabouraud liquid medium at 37 C, 110 rpm for 2 days. Then, the harvested mycelia of was washed three times by sterile PBS, then the supernatant was discarded without inactivation (for animals) or inactivated at 4 C overnight in 70% alcohol (for human corneal epithelial cells [HCECs]).7,23 The density of the fungal mycelia was read in a blood cell counting table, and diluted to the final concentration of 1 1 108 CFU/mL. The inactivated mycelia was stored at ?20 C. Cell Culture and Activation HCECs (ATCC CRL-11135, kindly provided by Ocular Surface Laboratory of Zhongshan Ophthalmic Center, Guangzhou, Guangdong, China) were cultured in DMEM with 10% fetal bovine serum (Gibco, Shanghai, China), 0.075% growth factor fibroblast growth factor 2 (Gibco), 0.075% insulin (Solarbio, Beijing, China), 1% penicillin G (Gibco), and streptomycin sulfate (Solarbio) in a humidified 5% CO2 incubator at 37 C.7 HCECs suspensions of 1 1 105/mL were seeded onto.